A 30-year-old homosexual man presented with wMespread Burkitt's lymphoma. On the basis of immunologic and viral studies, he was suspected of having the acquired immune deficiency syndr6me. Following chetiotherapy that incllided intrathecal cytoslne arabinoside and methotrexate, brain stem edema, paraplegia, and an elevated cembmspinal HUM level of myelln basic protein developed. A&p&y revealed vacuolar demyelinatlon of spinal cord, braiir stem, and cerebellum. The pathologic findings were similar td those reported to occur in myelopathy associated with intrathecal chemotherapy, but far more extensive. The contributidn df the suspected acquired immune deficiency syndrome is unknown.
Although a variety of toxicities have been reported after intrathecal chemotherapy, in many patients it may be difiicult to determine the relative contributions of the therapy and the underlying malighancy. Recently, there have been reports 6f the development of undifferentiated lymphoma in patients with the acquired immune deficiency syndrome (AIDS) [ 11. Since involvement of the nervous system by the lymphoma is common in such p&tier&, intrathecal chemotherapy is a vital component of treatment. Yet these patients are highly susceptible to a variety of infections, many involving the nervous system, and neurolqgic syndromes of unknown origin have also been described. Patients with this syndrdme may therefore be at particular risk of neurologic compiications of therapy.
We describe herein a 30-year-old homosexual man with extensive Burkitt's lymphoma and suspected AIDS in whom a myelopathy developed after chemotherapy that included intrathecal treatment. The myelopathy, which extended into the brain stem and resulted in increased intracranial pressure, was mor6 severe than cases previousiy reported and led to the patient's death. None of the neurologic disorders usually described in AIDS could account for the noninfiammatory vacuolar demyelination that involved spinal cord, brain stem, and cerebellum. However, an underlying abnormal imtiune system may have contributed to the extensive nature of the presuinptive neurotoxic ieaction.
CASE REPORi
A 30-year&Id white homosexual man was admitted with progressive stupor, fever, weakness, and disconjugate gaze. He had no significant past inedical history, but fcur mcnths earlier he had noted the onset of marked fatigue and an eight-pound weight loss. One month prior to admisQon, biopsy of an enlarged right cervical node revealed reactive hyperplasia. At that time, his hemoglobin level was 11.9 g/di, lactic dehydrogenase level 420 IWliter, and On. admission, he was cachectic and stuporous but responsive to questions. His temperature was 39'C, and respiratory rate 36 per minute. The right pupil was 6 mm and sluggishly reactive to light; the left was 3 mm and reacted normally. There was complete palsy of all extraocular muscles. Right-sided rales were noted on examination of the chest, and heat-t examination showed normal findings. Hepatosplenomegaly was present: the liver span was 17 cm and the spleen was papable 4 cm below the costal margin. The left testis was enlarged and indurated. Small ulcerated lesions from which herpes slmplex virus was cultured were observed on the buttocks. Mild generalized lymphadenopathy was noted.
The white blood cell count was 12,800/mm3, the hemoglobin level 10.3 g/dl, and the platelet count 81,000/mm3. Abnormal chemical values included: serum glutamic oxaloacetic transaminase 305 IWliter, serum glutamic pyruvic transaminase 165 IWliter, lactic dehydrogenase 3,7 10 IU/ liter, alkaline phosphatase 215 Ill/liter, uric acid 16 mg/dl, lactate 12.1 mg/dl, glucose 36 mg/dl, and creatine phosphokinase 1,400 Ill/liter (100 percent mm fraction). The cerebrospinal fluid was xanthochromic and bloody. Bilateral pleural effusions were seen on chest radiography. Uttrasound of the abdpmen demonstrated hepatosplenomegaly with two solid masses within the liver.
Results of tests for hepatitis B core and surface antibody were positive. Elevated titers to cytomegalovirus and Epstein-Barr virus were also noted (Table I) . Immunologic studies revealed marked depression of lymphocyte proliferation in response to cytomegalovlrus antigen and concanavalin A, elevated interferon levels, and an inverted T4:T8 ratio (0.42; normal greater than 1.6).
Burkitt's lymphoblasts were seen in the peripheral blood (1 percent), pleural fluid, and spinal fluid. Lymph node and bone marrow biopsy specimens revealed Burl&t's lymphoma. On the third hospital day, 1,900 mg of cyclophosphamide (1,200 mg/m*) was administered intravenously. Fifty milligrams of cytosine arabinoside (30 mg/m*) were given intfathecally on the second, third, fourth, and eighth hospital days. On the 12th hospital day, he received 12.5 mg of methotrexate intrathecally and a 42-hour infusion of high-dose methotrexate, followed by leucovorin rescue.
There was dramatic improvement with resolution of the pleural effusion, lymphadenopathy, hepatosplenomegaly, testicular enlargement, and abnormal chemical values, and an improvement in eye movement. Burkitt's cells were no longer seen in the spinal fluid. Repeated bone marrow biopsy revealed no lymphoma cells, and ultrasound showed resolution of the focal hepatic defects.
Lumbar puncture was performed on the 29th hospital day for a further intrathecal injection of cytosine arabinoskte. On the following day, his temperature rose to 38.6OC but an infectious cause was not confirmed. On the 35th hospital day, the patient received intravenously 1,824 mg of cyclophosphamide (1,200 mg/m*), 60 mg of doxorubicin hydrochloride (40 mg/m2), 2 mg of vincristine, and 60 mg of prednisone (40 mg/m*). He was also given two of three scheduled daily 50 mg doses of intrathecal cytosine arabinoside. After the first dose, nausea and vomiting developed, and after the second dose his temperature rose to 39.1°C. Results of multiple blood cultures remained negative. He complained of bilateral hip pain. Subsequently, there was decreasing responsiveness, hypertension, bradycardia, and hypothermia. There was no papilledema, and the lower extremities were flaccid with loss of pinprick sensation. Opening pressure on lumbar puncture was 30 cm of water. Cerebrospinal fluid protein level was 1,160 mg/dl and white cell count 21/mmS, but no tumor cells were present. After the lumbar puncture, obtundation and hypoventilation developed. Mannitol and dexamethasone were given. Computed tomography revealed brain stem edema, marked enlargement of both lateral ventricles, and obliteration of the third and fourth ventricles. After ventriculostomy, the patient's condition slowly improved. He was alert, able to squeeze with both hands, but unable to move his lower extremities despite painful stimuli. There was coarse horizontal nystagmus. Repeated scanning showed a marked decrease in the size of the ventricles. Six days after insertion, the shunt was removed and the patient became unresponsive. A major intracerebral hemorrhage was found by computed tomography, and he died on the following day. Autopsy revealed necrotic lymphoma in marrow and pleura, and fibrosis in the testes. There was a large fresh hemorrhage in the tract of the ventricular shunt, with blood in all ventricles and subarachnoid space.
Histologic examination showed noninflammatory, vacuolar demyelination of the white matter of the spinal cord (Figure l), brain stem, tuber cinereum, and cerebellum and myelinated axons of the cerebellar granular layer. The mildest changes consisted of multiple microvacuoles in myelin and axonal swellings (spheroids). Swelling of oligodendroglial cytoplasm was variably present, and multiple areas of demyelination with preferential loss of large diameter axons were also observed. Most of the damage was within white matter not more than 1 cm from$e subarachnoid space. In the spinal CoTd, vacuolar demyelination was bilateral and nearly symmetric. Myelin loss was most severe at depths of 100 to 1,000 microns from the outer margin of white matter (Figure 2) . A peripheral 50-to 2OO-micron rim of white matter in the region supplied by the arterial vasocorona was less affected. Damage overlapped adjacent tracts and was severe in the upper thoracic level. Medial portions of spinocerebellar tract and lateral portions of corticospjnal and spinothalamic, cuneate, gra@lis, and vestibulospinal tracts were involved. In the brain stem, vacuolar demyelination was most severe in the medulla where pyramids and olivocerebellar fibers were involved bilaterally. Corticospinal demyelination was present in the pons and cerebral peduncles.
Cerebellar vacuolar demyelination of the white matter was multifocal and most extensive in the folia. The demyelination extended to the granular cell layer without affecting the number of granular cells. As in other affected regions, axonal swellings were conspicuous (Figure 3 ).
There was no viable lymphoma, no lesions suggestive of toxoplasmosis, and organisms were not seen on special stains. rJ0 inflammation was present, viral inclusions were not found, and results of immunoperoxidase examinations for polyoma viruses were negative. Cerebrospinal fluid that had been stored during life was sent for myelin basic protein analysis. Results are shown in Figure 4 .
COMMENTS
The findings in this patient were probably a consequence of unusually severe neurotoxicity associated with intrathecal chemotherapy occurring in a patient with suspected AIDS. Shortly after intrathecal cytosine arabinoside, nausea, vomiting, and fever developed, followed by bilateral hip pain and lethargy and then by signs of an intracranial herniation.
There was evidence of paraplegia, which persisted until his death. It is not certain that this pitient's neurologic complications were unequivocally due to the chemotherapy. However, the temporal relationship of onset of symptoms to the in- Figure 2 . Peripheral vacuolar demyelination in longikfdinal section of lower thoracio spinal cord (hematoxylin and eosin stain; winal msgnifcation X 11.5, re&zed by 30 percent).
trathecal cytosine arabinoside is suggestive, particularly in view of the findings on pathologic examination. The clinical picture differed in some respects from that previously reported in cases in which myelopathy was associated with intrathecal chemotherapy. As in other cases, the onset was acute; there was a suggestion of radicular pain with the hip pain, and there was both motor and sensory loss. Unlike other cases, the pathologic changes extended into the brain stem, causing edema, cerebrospinal fluid outflow obstruction, and a herniation syndrome. Although the presence of AIDS in this patient cannot be proved, it was suspected in view of the usual clinical presentation for Burkitt's lymphoma, with widespread disease, and the associated immunologic study results including impaired lymphocyte proliferation and a decreased ratio of helper to suppressor T cells. Ziegler et al [l] recently described four homosexual males with a Burkitt's-like lymphoma. These patients also had unusual presentations for Burkii's lymphoma; three had central nervous system involvement.
Neurologic disorders have been reported in 10 to 20 percent of patients with AIDS. A large fraction of these patients have intracerebral mass lesions, frequently due to Toxoplasma gondii or npn-Hodgkin's lymphoma [3] . In some lesions, biopsy or autopsy material has been nondiagnostic, showing a few viral inclusion bodies or nonspecific inflammatory reaction.
Other prominent neurologic manifestations of AIDS include a progressive global dementia in v&i& cerebral biopsy specimens have shown nonspecific inflammatory changes and extensive demyelinization. Progressive multifocal leukoencephalopathy with cerebellar demyelination due to JC virus has also been reported [4] . Meningitis, particularly cryptococcal meningitis, has also been common, typically with subtle clinical presentations. Finally, a peripheral neuropathy of unknown origin has developed in many patients with AIDS. In the case presented, none of these possibilities could be shown to be responsible for the neurologic abnormalities.
Neurotoxicity associated with both cytosine arabinoside and methotrexate has been described. Methotrexate toxicity has included chemical arachnoiditis, paraparesis, and disseminated necrotizing leukoencephalopathy [ 5-81. Rarely, death has occurred im-mediately after intrathecal injection of methotrexate [9] . Neurotoxicity with cytosine arabinoside has been described less frequently, but transient or permanent paraparesis and seizures have been observed Multiple case reports of paraparesis following intrathecal cytosine arabinoside and methotrexate have appeared in the literature [5,7,9,10,12-221, with intrathecal methotrexate most commonly involved. Frequently there was radicular pain. The onset of dysfunction was usually immediate, and in most cases less than 40 hours. It was typically transient, but in some the neurologic deficits progressed or ascended over hours or days, with paraplegia and sensory levels as high as C7. In several cases, the deficit appeared permanent.
There are few reported cases of neurotoxicity associated with cytosine arabinoside alone. Wolff et al [ 121 described a 27-year-old patient with acute myelogenous leukemia who received central nervous system prophylaxis with five 170 mg (100 mg/m*) doses of intrathecal cytosine arabinoside and cranial irradiation, followed in one month by lower extremity paresthesias and weakness. Breuer et al [lo] reported a case of paraparesis following four 84 mg doses given for prophylaxis concurrent with cranial irradiation. Two weeks later, gait disturbance, lower extremity weakness, sensory loss, and urinary incontinence developed.
In none of these cases of paraplegia did herniation syndromes appear. However, Eden et al [ 1 l] reported the development of fever and generalized seizures after intrathecal cytosine arabinoside injection in two children. One of the children had signs of cerebral herniation that responded to dexamethasone and mannitol.
Various suggestions have been made concerning the pathogenesis of cytosine arabinoside or methotrexate neurotoxicity, but none of them has been proved [7, 10, 15, 18, 23] .
Only a few of the patients have undergone post mortem examination, which has revealed demyelination of the cord. Simple removal and reinjection of 1 cc aliquots of cerebrospinal fluid has been noted to cause demyelination with posterior extremity paralysis in cats [24] .
The syndrome of myelopathy following intrathecal chemotherapy is distinct from that of necrotizing leukoencephalopathy associated with systemic or intrathecal methotrexate and cranial irradiation [8, 8, 23, 25] . The latter syndrome is characterized by demyelination in the brain tissue plus multifocal necrosis, astrocytosis, and occasionally dystrophic calcification. Levels of myelin basic protein, which is specific to the myelin sheath, are elevated in the cerebrospinal fluid [21] , as in multiple sclerosis, in which levels of myelin basic protein correlate with the degree of active demyelination [26, 27] .
With few exceptions, cerebrospinal fluid myelin basic protein levels have not been recorded in patients with myelopathy due to intrathecal chemotherapy. Gangji et al [21] noted a transiently elevated level in a patient with acute-onset, right-sided hemiparesis after prophylactic intrathecal methotrexate and cranial irradiation. Clark et al [ 221 described a patient who had had numerous courses of intrathecal methotrexate and cytosine arabinoside for central nervous system leukemia of long duration, and in whom sensory loss and paraplegia developed accompanied by a myelin basic protein level of 17 rig/ml four weeks after bone marrow transplantation. A fatal ascending myelopathy characterized by a myelin basic protein level greater than 40 rig/ml developed in a patient at the National Cancer Institute after extensive treatment for central nervous system leukemia [28] . In the patient described herein, the myelin basic protein level was weakly positive (6.0 rig/ml) after four intrathecal injections of cytosine arabinoside. After the level normalized during a period free from drug administration, more intrathecal cytosine arabinoside was given and the level rose to 19 rig/ml coincident with neurologic deterioration.
Microscopic findings in the present case were very similar to findings in the cases reported by Breuer et al [lo] and Clark et al [22] . Major features in common were vacuolar myelin loss with axonal swellings but without necrosis or inflammation and with localization of the damage to myelin near the cerebrospinal fluid of the subarachnoid space. However, in the present case, destruction was not confined to the spinal cord. Vacuolar demyelination, microscopically identical to that seen in the spinal cord, affected multiple regions of brain stem and cerebellum. These regions had not been irradiated and were devoid of necrosis and calcification described in association with necrotizing leukoencephalopathy [6, 8, 23, 25] .
Thus, the myelopathy was more severe clinically and pathologically than any previously reported.
In summary, widespread Burkitt's lymphoma developed in a 30-year-old homosexual man with suspected AIDS. He had a complete clinical response to the first dose of cyclophosphamide but then had neurologic deterioration temporally related to intrathecal chemotherapy with cytosine arabinoside. Clinically, the initial manifestations were fever, nausea, vomiting, and bilateral hip pain. Following recovery from increased intracranial pressure due to brain stem edema, there was persistent paraplegia. On postmortem examination, extensive demyelination involving the cord and brain stem was seen, but without necrosis. Although it appeared to be a complication of intrathecal chemotherapy, a syndrome this extensive has not been previously described. Whether the suspected underlying AIDS may have been related to the development or severity of the demyelination syndrome is speculative. 
